A Unified Approach to Synthesizing Four Linezolid Metabolites That May Cause Thrombocytopenia
<b>Background/Objectives</b>: Linezolid is a first-in-class oxazolidinone antibiotic that exhibits activity against Gram-positive pathogens, including methicillin-resistant <i>Staphylococcus aureus</i> and vancomycin-resistant enterococci. However, its clinical use is often restricted because of hem...
Salvato in:
| Autori principali: | , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
MDPI AG
2025-11-01
|
| Serie: | Pharmaceuticals |
| Soggetti: | |
| Accesso online: | https://www.mdpi.com/1424-8247/18/12/1821 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|